393 related articles for article (PubMed ID: 28000527)
1. Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?
Ali MA; Matboli M; Tarek M; Reda M; Kamal KM; Nouh M; Ashry AM; El-Bab AF; Mesalam HA; Shafei AE; Abdel-Rahman O
Immunotherapy; 2017 Jan; 9(1):99-108. PubMed ID: 28000527
[TBL] [Abstract][Full Text] [Related]
2. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression.
Saleh R; Toor SM; Sasidharan Nair V; Elkord E
Front Immunol; 2020; 11():1469. PubMed ID: 32760400
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic modulation in cancer immunotherapy.
Gallagher SJ; Shklovskaya E; Hersey P
Curr Opin Pharmacol; 2017 Aug; 35():48-56. PubMed ID: 28609681
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors.
Terranova-Barberio M; Thomas S; Munster PN
Immunotherapy; 2016 Jun; 8(6):705-19. PubMed ID: 27197539
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics and immunotherapy: The current state of play.
Dunn J; Rao S
Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
[TBL] [Abstract][Full Text] [Related]
6. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors.
Pitt JM; Vétizou M; Daillère R; Roberti MP; Yamazaki T; Routy B; Lepage P; Boneca IG; Chamaillard M; Kroemer G; Zitvogel L
Immunity; 2016 Jun; 44(6):1255-69. PubMed ID: 27332730
[TBL] [Abstract][Full Text] [Related]
7. Cancer Epigenetics, Tumor Immunity, and Immunotherapy.
Cao J; Yan Q
Trends Cancer; 2020 Jul; 6(7):580-592. PubMed ID: 32610068
[TBL] [Abstract][Full Text] [Related]
8. Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy.
Liu M; Zhou J; Chen Z; Cheng AS
J Pathol; 2017 Jan; 241(1):10-24. PubMed ID: 27770445
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential.
Maes K; Mondino A; Lasarte JJ; Agirre X; Vanderkerken K; Prosper F; Breckpot K
Front Immunol; 2021; 12():652160. PubMed ID: 33859645
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Cancer Vaccines-T Cell Responses and Epigenetic Modulation.
Kartikasari AER; Prakash MD; Cox M; Wilson K; Boer JC; Cauchi JA; Plebanski M
Front Immunol; 2018; 9():3109. PubMed ID: 30740111
[TBL] [Abstract][Full Text] [Related]
11. Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy.
Maio M; Covre A; Fratta E; Di Giacomo AM; Taverna P; Natali PG; Coral S; Sigalotti L
Clin Cancer Res; 2015 Sep; 21(18):4040-7. PubMed ID: 26374074
[TBL] [Abstract][Full Text] [Related]
12. The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy.
Loo Yau H; Ettayebi I; De Carvalho DD
Trends Cell Biol; 2019 Jan; 29(1):31-43. PubMed ID: 30153961
[TBL] [Abstract][Full Text] [Related]
13. Leveraging epigenetics to enhance the efficacy of immunotherapy.
Licht JD; Bennett RL
Clin Epigenetics; 2021 May; 13(1):115. PubMed ID: 34001289
[TBL] [Abstract][Full Text] [Related]
14. Cancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation.
Yaguchi T; Kawakami Y
Int Immunol; 2016 Aug; 28(8):393-9. PubMed ID: 27401477
[TBL] [Abstract][Full Text] [Related]
15. Targeting epigenetic mechanisms for clinical translation: enhancing the efficacy of tumor immunotherapies.
Kosoff D; Krueger T; Lang JM
Immunotherapy; 2013 Nov; 5(11):1243-54. PubMed ID: 24188678
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics meets immune checkpoints.
Covre A; Coral S; Di Giacomo AM; Taverna P; Azab M; Maio M
Semin Oncol; 2015 Jun; 42(3):506-13. PubMed ID: 25965370
[TBL] [Abstract][Full Text] [Related]
17. Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.
Shi T; Ma Y; Yu L; Jiang J; Shen S; Hou Y; Wang T
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29735917
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy.
Park J; Thomas S; Munster PN
Epigenomics; 2015; 7(4):641-52. PubMed ID: 26111034
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Strategies to Boost Cancer Immunotherapies.
Barrero MJ
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545238
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors.
Perrier A; Didelot A; Laurent-Puig P; Blons H; Garinet S
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
